OBSIDIAN THERAPEUTICS Trademark

Trademark Overview

On Thursday, February 4, 2016, a trademark application was filed for OBSIDIAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OBSIDIAN THERAPEUTICS trademark a serial number of 86897213. The federal status of this trademark filing is REGISTERED as of Tuesday, February 20, 2018. This trademark is owned by Obsidian Therapeutics, Inc.. The OBSIDIAN THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development in the field of gene therapy
obsidian therapeutics

General Information

Serial Number86897213
Word MarkOBSIDIAN THERAPEUTICS
Filing DateThursday, February 4, 2016
Status700 - REGISTERED
Status DateTuesday, February 20, 2018
Registration Number5408050
Registration DateTuesday, February 20, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2016

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 1, "Obsidian Therapeutics" should be deleted, and "Obsidian Therapeutics, Inc." should be inserted.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development in the field of gene therapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 9, 2016
Primary Code042
First Use Anywhere DateSaturday, December 16, 2017
First Use In Commerce DateSaturday, December 16, 2017

Trademark Owner History

Party NameObsidian Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameObsidian Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameObsidian Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, February 8, 2016NEW APPLICATION ENTERED
Tuesday, February 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 20, 2016ASSIGNED TO EXAMINER
Sunday, May 22, 2016NON-FINAL ACTION E-MAILED
Sunday, May 22, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, May 22, 2016NON-FINAL ACTION WRITTEN
Monday, May 23, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 1, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 1, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 2, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, June 9, 2016POST PUBLICATION AMENDMENT RECEIVED
Thursday, June 9, 2016ASSIGNED TO PETITION STAFF
Friday, June 10, 2016CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, June 15, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 5, 2016PUBLISHED FOR OPPOSITION
Tuesday, July 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 14, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 14, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017SOU EXTENSION 1 FILED
Tuesday, February 14, 2017SOU EXTENSION 1 GRANTED
Thursday, February 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 15, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 15, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 15, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 15, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 21, 2017SOU TEAS EXTENSION RECEIVED
Monday, August 21, 2017SOU EXTENSION 2 FILED
Monday, August 21, 2017SOU EXTENSION 2 GRANTED
Wednesday, August 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 2, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, January 2, 2018USE AMENDMENT FILED
Monday, January 15, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 15, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 16, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 17, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 20, 2018REGISTERED-PRINCIPAL REGISTER
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 18, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 6, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 6, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 20, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, February 14, 2024TEAS SECTION 8 & 15 RECEIVED
Thursday, February 15, 2024TEAS SECTION 7 REQUEST RECEIVED
Wednesday, September 11, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 16, 2024CORRECTION UNDER SECTION 7 - PROCESSED
Thursday, September 19, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Related Keywords

therapeutics obsidian gene therapy field development research pharmaceutical